AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

CHLORHYDRATE DE LOPERAMIDE

9 registrations across 2 African markets— 6 active

Markets with CHLORHYDRATE DE LOPERAMIDE

Recent registrations

Brand / ProductMarketHolderStatusExpires
IMODIUM 2MG GELULE BOITE DE 20🇨🇮Côte d'IvoireJANSSEN CILAG INTERNATION NVactiveNov 2028
LOPERIUM 2MG GELULE BOITE DE 20🇨🇮Côte d'IvoireLABORATOIRE BOTTU S.AexpiredMar 2024
LOPERAMIDE UBI 2MG GELULE BOITE DE 100🇨🇮Côte d'IvoireUBITHERA PHARMA PVT. LTDexpiredFeb 2024
LOPERAMIDE CREAT 2MG GELULE BOITE DE 20🇨🇮Côte d'IvoireBAILLY CREATexpiredDec 2018
LOPERIUM
gélule / 2 mg
🇸🇳SenegalBOTTU SAactive
LOPHYDINE
gélule / 2 mg
🇸🇳SenegalSANDOZ GMBHactive
STADIAR
gélule / 2 mg
🇸🇳SenegalLAPROPHANactive
DIARUM 0,2MG/ML SUSPENSION BUVABLE FLACON DE 100ML🇨🇮Côte d'IvoirePHARMA PRODUCT MANUFACTURING (PPM)active
DIARUM 2MG GELULE BOITE DE 20🇨🇮Côte d'IvoirePHARMA PRODUCT MANUFACTURING (PPM)active

CHLORHYDRATE DE LOPERAMIDE in Africa — Regulatory Overview

CHLORHYDRATE DE LOPERAMIDE is registered across 2 African markets with 9 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Côte d'Ivoire, Senegal. AfricaRegulatory refreshes this data daily from official government sources.

Of the 9 registrations, 6 (67%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.